Sensex had dropped 1,010.90 points to 82,283.76, while the National Stock Exchange (NSE) of India Nifty50 was down 287.25 points at 25,425.75.
Latest News
Asian shares are mixed after heavy selling of potential AI losers hits Wall Street
BANGKOK (AP) — Asian shares were mixed Tuesday after U.S. stocks slumped on heavy selling of shares in companies that could be losers in
Ruling against Trump’s tariffs creates new uncertainty in US trade relations with China
WASHINGTON (AP) — The Supreme Court decision striking down President Donald Trump’s sweeping tariffs has added a wrinkle to already complicated U.S.-China relations, with
Morgan Stanley resets Nvidia stock forecast ahead of earnings
Investors are eagerly waiting for Nvidia‘s (NVDA) Q4 earnings, scheduled for February 25. The last earnings report was an absolute smasher, yet the stock
Software stocks are tanking the market again as AI and tariff uncertainty spook traders
Fears of a software apocalypse are pummeling markets again to start the week. US stocks dropped on Monday as traders reacted to new tariff
More borrowers seek financial counseling as credit card rates near record highs
SALT LAKE CITY (KUTV) — President Donald Trump’s push to get credit card companies to voluntarily cap interest rates at 10% has gone nowhere.
Tariffs are here to stay regardless of court ruling: UBS Global Wealth Management
Adrian Zuercher of UBS Global Wealth Management explains why he believes the U.S. Supreme Court’s ruling against President Donald Trump’s tariff strategy will not
Stock market today: Dow drops 800 points as S&P 500, Nasdaq slide on Trump tariff fears, AI 'scare trade'
Domino’s (DPZ) posted mixed fourth quarter and fiscal 2025 results as the chain doubles down on growing sales, store count, and profits while consumers
Stock futures are little changed after major indexes sell off on anxiety over AI disruption, tariffs: Live updates
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., Feb. 23, 2026. Brendan Mcdermid | Reuters
Stock Market Today, Feb. 23: ImmunityBio Surges After Anktiva Revenue Jumps 700%
ImmunityBio (NASDAQ:IBRX), a developer of cancer and infectious-disease immunotherapies, closed Monday at $9.83, up 12.99%. The stock moved higher after earnings highlighted 700% ANKTIVA